100 related articles for article (PubMed ID: 18802168)
21. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
Sipos L; Vitanovics D; Afra D
Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
[TBL] [Abstract][Full Text] [Related]
22. Temozolomide may induce therapy-related acute lymphoblastic leukaemia.
Ogura M; Todo T; Tanaka M; Nannya Y; Ichikawa M; Nakamura F; Kurokawa M
Br J Haematol; 2011 Sep; 154(5):663-5. PubMed ID: 21518332
[No Abstract] [Full Text] [Related]
23. Temozolomide treatment in glioma--experiences in two university hospitals in Finland.
Mäenpää HO; Aaltonen K; Mäntylä R; Minn H
Acta Oncol; 2004; 43(6):579-84. PubMed ID: 15370616
[TBL] [Abstract][Full Text] [Related]
24. Temozolomide for relapsed primary CNS lymphoma.
Osmani AH; Masood N
J Coll Physicians Surg Pak; 2012 Sep; 22(9):594-5. PubMed ID: 22980617
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma.
Wick A; Felsberg J; Steinbach JP; Herrlinger U; Platten M; Blaschke B; Meyermann R; Reifenberger G; Weller M; Wick W
J Clin Oncol; 2007 Aug; 25(22):3357-61. PubMed ID: 17664483
[TBL] [Abstract][Full Text] [Related]
26. Comment on "Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma".
Gousias K; Kyritsis A
J Clin Neurosci; 2010 Mar; 17(3):412. PubMed ID: 20079651
[No Abstract] [Full Text] [Related]
27. Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98).
Broniscer A; Iacono L; Chintagumpala M; Fouladi M; Wallace D; Bowers DC; Stewart C; Krasin MJ; Gajjar A
Cancer; 2005 Jan; 103(1):133-9. PubMed ID: 15565574
[TBL] [Abstract][Full Text] [Related]
28. Temozolomide for recurrent low-grade spinal cord gliomas in adults.
Chamberlain MC
Cancer; 2008 Sep; 113(5):1019-24. PubMed ID: 18615600
[TBL] [Abstract][Full Text] [Related]
29. Management of cytomegalovirus infection in a patient with malignant glioma treated with temozolomide and steroids.
Okita Y; Narita Y; Miyakita Y; Ohno M; Nagai S; Shibui S
Intern Med; 2012; 51(20):2967-71. PubMed ID: 23064578
[TBL] [Abstract][Full Text] [Related]
30. Temozolomide in the treatment of recurrent malignant glioma.
Chang SM; Theodosopoulos P; Lamborn K; Malec M; Rabbitt J; Page M; Prados MD
Cancer; 2004 Feb; 100(3):605-11. PubMed ID: 14745879
[TBL] [Abstract][Full Text] [Related]
31. Phase I dose-escalation and pharmacokinetic study of temozolomide (SCH 52365) for refractory or relapsing malignancies.
Brada M; Judson I; Beale P; Moore S; Reidenberg P; Statkevich P; Dugan M; Batra V; Cutler D
Br J Cancer; 1999 Nov; 81(6):1022-30. PubMed ID: 10576660
[TBL] [Abstract][Full Text] [Related]
32. Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study.
Lashford LS; Thiesse P; Jouvet A; Jaspan T; Couanet D; Griffiths PD; Doz F; Ironside J; Robson K; Hobson R; Dugan M; Pearson AD; Vassal G; Frappaz D;
J Clin Oncol; 2002 Dec; 20(24):4684-91. PubMed ID: 12488414
[TBL] [Abstract][Full Text] [Related]
33. Pneumocystis jirovecii pneumonia prophylaxis during temozolomide treatment for high-grade gliomas.
De Vos FY; Gijtenbeek JM; Bleeker-Rovers CP; van Herpen CM
Crit Rev Oncol Hematol; 2013 Mar; 85(3):373-82. PubMed ID: 22925496
[TBL] [Abstract][Full Text] [Related]
34. [Glioma therapy up-date].
de la Fuente BP; Dalmau J; Rosenfeld M
Neurologia; 2007 Apr; 22(3):159-69. PubMed ID: 17364254
[TBL] [Abstract][Full Text] [Related]
35. Schedule-dependent activity of temozolomide plus CPT-11 against a human central nervous system tumor-derived xenograft.
Patel VJ; Elion GB; Houghton PJ; Keir S; Pegg AE; Johnson SP; Dolan ME; Bigner DD; Friedman HS
Clin Cancer Res; 2000 Oct; 6(10):4154-7. PubMed ID: 11051270
[TBL] [Abstract][Full Text] [Related]
36. [Unknown gonadotoxicity chemotherapy and preservation of fertility: example of Temozolomide].
Sitbon Sitruk L; Sanson M; Prades M; Lefebvre G; Schubert B; Poirot C
Gynecol Obstet Fertil; 2010 Nov; 38(11):660-2. PubMed ID: 21030284
[TBL] [Abstract][Full Text] [Related]
37. [Temozolomide in the treatment of recurrent malignant glioma].
Kobayashi H; Sawamura Y; Ishii N; Murata J; Iwasaki Y
No Shinkei Geka; 2006 Dec; 34(12):1241-7. PubMed ID: 17154070
[TBL] [Abstract][Full Text] [Related]
38. Temozolomide for melanoma: new toxicities and new opportunities.
Gajewski TF
J Clin Oncol; 2004 Feb; 22(4):580-1. PubMed ID: 14726506
[No Abstract] [Full Text] [Related]
39. Therapy-related megakaryoblastic leukemia with pituitary involvement following treatment for non-Hodgkin's lymphoma.
Saitoh T; Morimoto K; Kumagai T; Saiki M; Tanaka M; Aikawa S; Tsuboi I; Sawada U; Horie T
Intern Med; 1999 Nov; 38(11):904-9. PubMed ID: 10563755
[TBL] [Abstract][Full Text] [Related]
40. Secondary Ph+ acute lymphoblastic leukemia after temozolomide.
De Vita S; De Matteis S; Laurenti L; Chiusolo P; Reddiconto G; Fiorini A; Leone G; Sica S
Ann Hematol; 2005 Oct; 84(11):760-2. PubMed ID: 16044311
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
